Telemedicine & Phone Consultations Available NOW!

Logo

Doxycycline for Cancer Killing

There are 2 ribosomes in the mitochondrial, a smaller (28s) and a larger (29s) one.

The doxycycline targets only the smaller ribosome (28s) inhibiting its protein production. Proteins produced by mitochondrial ribosomes are incorporated into complex 1 through 4 of the electron transport chain. This help kill the cancer.

What if we could use a second drug to simultaneously block the larger 39 s ribosome and induce more profound inhibition of protein production and inhibition of cancer. This is an oxidative phosphorylation inhibitor. This can help kill your cancer.

What if we could use a second drug to simultaneously block the larger 39 s ribosome and induce more profound inhibition of protein production and inhibition of cancer. This is an oxidative phosphorylation inhibitor. This can help kill your cancer.

This is exactly what was done in 2019 by Dr. Fiorillo where he added a common antibiotic called azithromycin that targets the larger ribosome (29s). There was greater cancer inhibition. The study showed that doxycycline may be considered an effective stand-alone anticancer therapy. In 2016, Dr. Chen studied 21 cancer cell lines in vitro and 4 kinds of tumor bearing mouse models in vivo. He found that many of the cancer cell lines were very sensitive to doxycycline, killing them at low concentrations. He made the remarkable observation that doxycycline was more affected than the standard chemotherapy drug cyclophosphamide.

In 2015 doctor’s David Barbie and Brian Kennedy studied the effects of doxycycline on B-cell lymphoma. They found that it accumulates in lymphoma cells in high concentrations. “Notably, doxycycline was also effective at inhibiting the growth of diffuse large B-cell lymphoma at physiologic achievable doses “

Doxycycline has been studied in breast cancer and has been shown to decrease the marker LC3B. This is a specific biomarker autophagy. This means that there is suppression of proliferation, invasion, and self-renewal of breast cancer cells. The potent inhibition of cancer stem-like characteristics and breast cancer cells by doxycycline treatments suggest this drug can be re-purposed as an anticancer drug in the treatment of breast cancer.

In addition, doxycycline has potent anti-inflammatory effects with the 50% reduction in TN Kappa B.

Doxycycline has been used for various cancer cell types including breast cancer, melanoma, glioblastoma, leukemia, T-cell lymphoma, cervical cancer, breast cancer stem cells, prostate cancer stem cells, small cell lung cancer adenocarcinoma of duodenum, and others

Combination therapy works best. We used a combination of low-dose genomic metronomic chemotherapy, natural substances, various cancer vaccines, and re-purposed drugs such as doxycycline and azithromycin in addition to many others.

If you would like more information, please contact us at 480-361-7020

Testimonials

Contact Us

Have an emergency or need a consultation? Book your visit with us.

Contact Us